What is the current price and market cap of AIDX.TO stock?

AIDX.TO stock trades at **C$0.90** pre-market on 23 Mar 2026. Market cap is **C$225,502,192** with **278,397,768** shares outstanding. Volume today is **354,239** versus an average of **563,025** shares.

How did Healwell AI perform in the latest earnings release for AIDX.TO stock?

Healwell reported Q4 revenue of **C$32.20 million**, a **374.00%** year-over-year increase. The company still posts a negative EPS of **-C$0.23** and negative operating cash flow per share **-C$0.10**, so growth has not yet translated to positive earnings.

What forecast and rating does Meyka AI provide for AIDX.TO stock?

Meyka AI rates AIDX.TO **62.02/100 (Grade B, HOLD)**. The model projects monthly **C$0.65**, quarterly **C$0.72**, and yearly **C$0.40**. These are model-based projections and not guarantees.

What are the main risks for AIDX.TO stock investors?

Key risks include tight liquidity (current ratio **0.85**), negative cash flow, and a third-party company rating of **D+**. The stock also faces sector pressure and volume volatility common in healthcare AI names.

CA Stocks

C$0.90 pre-market 23 Mar 2026: Healwell AI (AIDX.TO TSX) Q4 revenue up, watch targets

ByHuzaifa Zahoor March 23, 2026March 23, 2026

Healwell AI Inc. (AIDX.TO stock) opens pre-market at C$0.90 on 23 Mar 2026 after reporting a Q4 revenue surge. The company reported revenue of C$32.20 million for Q4, a 374.00% year-over-year increase that reshapes near-term cash flow expectations. Investors must weigh that growth against a negative EPS of -C$0.23 and a price-to-sales ratio of 2.28. We examine the Q4 drivers, key ratios, technical signals, and our scenario-based price targets for this TSX-listed healthcare AI name.